Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23896100 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Provenge (TM) for the Treatment of Hormone Sensitive Prostate Cancer
Condition: Prostate Cancer
Interventions: Other: Placebo;   Biological: Provenge

Indicates status has not been verified in more than two years